Gene discovery could lead to new sepsis treatments: 3 things to know

Researchers from Australian National University in Canberra and the Garvan Institute of Medical Research in Darlinghurst, Australia, have identified a gene that triggers the inflammatory conditions that result in sepsis.

Advertisement

Here are three things to know about the finding.

• Prior to this discovery, researchers were aware sepsis occurred when molecules on the surface of certain bacteria infiltrated cells. This would result in an immune response that causes the cells to “self-destruct.”
• The newly identified gene, Gasdermin-D, is what they now believe deploys a protein that triggers cell death in the instance of bacterial invasion.
• In addition to enabling a better understanding of inflammatory diseases beyond sepsis, the researchers said the finding could potentially enable them to identify a mechanism to shut down sepsis before it becomes life-threatening.

More articles on infection control:

Medication errors occur in half of all surgeries: 7 things to know
California hospitals says endoscope was cleaned improperly for 7 years
5 essential components of a successful antibiotic stewardship program

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.